Corporate Facts
| HEADQUARTERS | 531 South Spring Street Burlington, North Carolina 27215 |
| TICKER SYMBOL | LH |
| NUMBER OF EMPLOYEES | More than 80,000 worldwide |
| ANNUAL REVENUE | $14.9 Billion (2022) |
| CHIEF EXECUTIVE OFFICER | Adam H. Schechter |
| PATIENT ACCESS POINTS | Labcorp provides patient access points strategically and conveniently located throughout the United States, including nearly 2,000 PSCs and more than 6,000 in-office phlebotomists located in customer offices and facilities. |
| LABCORP SPECIALTY TESTING |
Labcorp is an industry leader in gene-based and esoteric testing and provides a range of frequently requested and specialty testing services, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women’s health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs and kidney stone prevention. |
| OUR BUSINESS |
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With over 80,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14.9 billion in FY2022. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp. Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH. |
| CONTACT PERSON | Rachael Valdez 336-436-8263 [email protected] |